ACell Inc.

Description

Magnus Moliteus has served as a member of our board of directors since 2012. Mr. Moliteus has been a consultant to the healthcare industry and Chairman of COM Consulting, a privately held firm, which enhances Swedish-American relations particularly between health care companies, since 2001. He served on the Board of Directors, and as Chairman of the Compensation Committee, of DUSA Pharmaceuticals Inc., and was a member of DUSA’s Acquisition and Business Development Committee from 2003 to 2012. Mr.

Founded in 2002 and headquartered in Columbia, Maryland, with more than 300 employees in the United States, ACell celebrated its initial commercial launch in 2010.

ACell is a leading regenerative medicine company focused on the development, manufacturing and commercialization of MatriStem products based on our proprietary urinary bladder matrix (UBM) technology platform. ACell aspires to be the recognized leader in regenerative extracellular matrix (ECM) technology, offering superior healing options for doctors and patients. We are a dedicated team creating high-quality, innovative solutions that we believe will transform standards of medical care, improving the quality of life of every patient for whom our products are used.

Martin Pfinsgraff has served as a member of our board of directors since 2010. Mr. Pfinsgraff serves as the Senior Deputy Comptroller for Large Bank Supervision at the Office of the Comptroller of the Currency. Mr. Pfinsgraff brings more than 30 years of experience in finance and risk management across the banking, insurance, and securities industry. Mr. Pfinsgraff previously served in various executive positions at Prudential Financial, Mellon Bank, and iJET International. Mr.

Fact sheet

Company contacts

Products & services

Similar companies nearby